Key facts
- This page summarizes Don Healey's Form 4 filing for Adicet Bio, Inc. (ACET).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Aug 2022, 20:26.
Don Healey - 04 Aug 2022 Form 4 Insider Report for Adicet Bio, Inc. (ACET)
- Reporting relationship
- Chief Technology Officer
- Issuer ticker
- ACET
- Reported as of
- 04 Aug 2022
- Net transaction value
- -$100,977
- SEC form
- 4
- Accepted by SEC
- 08 Aug 2022, 20:26:23 UTC
- Prior SEC filing
- 16 Feb 2022
- Next SEC filing
- 04 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nick Harvey, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Don Healey filed Form 4 for Adicet Bio, Inc. (ACET) on 08 Aug 2022.
Change
- Previous filing in this sequence was filed on 16 Feb 2022.
- Current net transaction value: -$100,977.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ACET
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +16,000
- Change %
- +30%
- Price
- $0.000000
- Shares after
- 68,934
- Date
- 04 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
ACET
transaction
Common Stock
Tax liability
- Transaction value
- $100,977
- Shares
- -5,533
- Change %
- -8%
- Price
- $18.25*
- Shares after
- 63,401
- Date
- 04 Aug 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Reporting Person was issued 80,000 Restricted Stock Units ("RSUs") on October 1, 2021, as previously reported on a Form 4 filed by the Reporting Person on October 5, 2021. Each RSU represents a contingent right to receive one share of common stock. A total of 32,000 of the RSUs shall vest in two (2) annual installments of 20% of the shares vesting, with the first tranche vesting on October 1, 2022 and the second tranche vesting on October 1, 2023. A total of 48,000 of the RSUs shall vest upon achievements of specific milestones outlined in the Reporting Person's Restricted Stock Unit Agreement. On August 4, 2022, upon the occurrence of the third performance milestone, 16,000 of the RSUs vested. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.